drugset / Trial / NCT00697970
Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of the present trial is to evaluate 6 vaccine formulations of recombinant hepatitis B vaccine for their reactogenicity and immunogenicity when administered at 0-2 months with a booster at month 12
Timeline
- Start
- 1993-11
- Primary completion
- 1995-04
- Completion
- 1995-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Engerix-B | Vaccine | — | Intramuscular |
| Subject | Hepatitis B vaccine | Vaccine | — | Intramuscular |